Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Always consult a healthcare professional to ensure safe and effective use
Click here for the latest stock market news and in-depth analysis, including events that move stocks Read the latest financial and business news from Yahoo Finance
Adjuvant nivolumab in muscle-invasive urothelial carcinoma: exploratory biomarker analysis of the randomized phase 3 CheckMate 274 trial
If either compound has lower-than-stated purity or content, the actual administered dose differs from the calculated dose, compromising research validity
US$ 27.88
US$ 22.14
US$ 23.06
US$ 27.40
US$ 25.49
US$ 27.46
US$ 24.41
US$ 28.93
